ACC.26 - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image of resistant hypertension screening and cortisol-related disease, illustrating Corcept Therapeutics’ MOMENTUM trial findings on hypercortisolism prevalence in difficult-to-treat blood pressure patients.

Corcept Therapeutics (NASDAQ: CORT) puts resistant hypertension in the cortisol spotlight with new MOMENTUM trial data

Representative image of the United States Capitol as the Department of Homeland Security shutdown fight deepens, with the House passing a 60-day funding bill that Senate Democrats say they will block.

DHS shutdown set to drag on as House sends Senate a bill Democrats vow to block

Representative image of oral hidradenitis suppurativa treatment research as Incyte Corporation reports positive 54-week povorcitinib Phase 3 data, highlighting the race to expand HS therapy options.

Incyte (NASDAQ: INCY) moves closer to an hidradenitis suppurativa launch as 54-week povorcitinib data hold up

Devdutt Padikkal scores fastest IPL fifty as RCB crush SRH in IPL 2026 season opener

Representative image of a blood pressure monitor and injectable therapy concept, illustrating Kardigan’s tonlamarsen Phase 2 hypertension study and its post-hospital acute severe hypertension strategy.

Read More

Pharma Industry News

Kardigan’s tonlamarsen data put acute severe hypertension into sharper commercial focus

Kardigan’s tonlamarsen Phase 2 data showed blood pressure promise despite mixed endpoints. Read what it means for acute severe hypertension next.

March 29, 2026

web analytics